Moreover, IH-induced dyslipidemia can also be related to decreased lipoprotein clearance due to the inhibition of lipoprotein lipase (LPL) mediated by HIF-1 and Angiopoietin-Like 4 (Angptl4) [249,277,278]. This evidence concerns the gene LPL and metabolic syndrome.